	Endoresection in Choroidal Melanoma: Outcomes of Intentional Incomplete Tumor Removal. Curr Oncol Anduaga-Beramendi A, Caminal-Caramés M, Lorenzo D, Cobos E, Mateos-Olivares M, Garcia-Bru P, Morwani R, Santamaría J, Garcia-Garcia O, Arias L, Caminal JM. PMID: 41440216 [PubMed - indexed for MEDLINE]
	Attention-Based Multimodal Deep Learning for Uveal Melanoma Classification Using Ultra-Widefield Fundus Images and Ocular Ultrasound. Ophthalmol Sci Dadzie AK, Iddir SP, Abtahi M, Ebrahimi B, Rahimi M, Ganesh S, Son T, Heiferman MJ, Yao X. PMID: 41439217 [PubMed]
	Cytotoxicity and apoptotic effects of the ethyl acetate fraction of Zanthoxylum acanthopodium DC fruit on B16F10 melanoma cell culture. Contemp Oncol (Pozn) Megawati ER, Bangun H, Putra IB, Rusda M. PMID: 41438810 [PubMed]
	Towards evidence-based policy in melanoma screening and skin self-examination education. J Eur Acad Dermatol Venereol Ozdemir SO, Shourick J. PMID: 41431948 [PubMed - in process]
	Clinical and pathological characteristics and correlation analysis of anorectal malignant melanoma. Medicine (Baltimore) Xi L, Zhou J, Wu Y, Zhai B, Rong R. PMID: 41431001 [PubMed - indexed for MEDLINE]
	Germline Cancer Susceptibility Gene Testing in Unselected Patients with Malignant Melanoma: A Multicenter Prospective Study. J Am Acad Dermatol Costello CM, Ho A, Kechter J, Nussbaum RL, Esplin ED, Branoff J, Kunze KL, Golafshar MA, Samadder NJ, Mangold AR. PMID: 41429209 [PubMed - as supplied by publisher]
	Charting the growth of programmed cell death studies in uveal melanoma: a bibliometric evidence. Discov Oncol Zhang J, Li L. PMID: 41428110 [PubMed - as supplied by publisher]
	CD39(+)PD-1(+) regulatory T cells in melanoma: key drivers of systemic immunosuppression and prognostic biomarkers. Front Oncol Qiao G, He H, Wang X. PMID: 41426337 [PubMed]
	Global Burden and Trends of Cutaneous Malignant Melanoma in the Elderly Population: Analysis of Global Burden of Disease Study 2021. Clin Cosmet Investig Dermatol Du Z, Li X, Tan W, Wang C, Wang G, Wei H, Pan Y, Wu S, Zhou Q, Lin H. PMID: 41425115 [PubMed]
	Therapeutic properties of plant-derived prebiotics in melanoma. Explor Target Antitumor Ther Kay E, Kazi M, Burton J, Parvathy SN. PMID: 41424605 [PubMed]
	Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801. Clin Transl Oncol Cerezuela-Fuentes P, Piñero-Madrona A, Muñoz-Couselo E, Manzano JL, Berciano-Guerrero MÁ, Majem M, Espinosa E, Soria A, Ayala de Miguel P, García Castaño A, Crespo G, Gutiérrez Sanz L, Aguado de la Rosa C, Fernández-Morales LA, Puértolas T, Fra Rodríguez J, Rodríguez de la Borbolla M, Bellido L, López Castro R, Navarro Pérez V, García Arroyo FR, Villa Guzmán JC, Campos Balea B, Hernández B, Martín Algarra S, Márquez-Rodas I. PMID: 41420791 [PubMed - as supplied by publisher]
	Melanoma treatment in the era of nanotechnology and precision medicine. J Nanobiotechnology da Cruz AF, Colella F, Grasso G, Onesto V, Forciniti S, Ortiz BB, Carnevali F, Siciliano AC, Bove R, Gonçalves Dos Santos J, Iuele H, Zub EC, Gigli G, Del Mercato LL, Camargo de Oliveira C. PMID: 41419864 [PubMed - as supplied by publisher]
	Prospective standardized surveillance of early-stage melanoma on the basis of anatomical staging and molecular profiling: Study design and interim analysis. Surgery Aubrey JM, Kelley J, Khan M, Kolbeinsson H, Liefeld H, Preihs R, Bengel A, Koch C, Martin L, Charchan J, Texley-Quigg K, Melnik M, Wright GP. PMID: 41419392 [PubMed - as supplied by publisher]
	Enhancing Diagnostic Precision in Primary Care: A Multireader Multicase (MRMC) Study of an AI-Powered Handheld Elastic Scattering Spectroscopy Device for Informed Referral Decisions in Melanoma Evaluation. J Clin Aesthet Dermatol Seiverling EV, Shah A, Weinstock MA, Grant-Kels JM, Falk NP, Siegel DM. PMID: 41416030 [PubMed]
	Competing risk analysis of prognosis in patients with uveal melanoma. Discov Oncol Huang R, Chen J, Lyu J, Zhou Q, Lin L. PMID: 41413733 [PubMed - as supplied by publisher]
	Independent Dutch Validation Study of CP-GEP (Merlin Assay) for the Prediction of Nodal Metastasis and Long-Term Outcome in Patients with Primary Cutaneous Melanoma. Ann Surg Oncol Zijlker LP, Verwer Z, van der Wiel BA, Kuijpers AMJ, Wouters MWJM, van Houdt WJ, van Akkooi ACJ. PMID: 41413281 [PubMed - as supplied by publisher]
	P22 Using VECTRA and AI analysis to monitor paediatric lesions: a review of cases. Br J Dermatol Baird J, Murrell D. PMID: 41412984 [PubMed - indexed for MEDLINE]
	Exploring the Impact of Foods and Dietary Patterns on Melanoma Risk. Cureus Kalavsky M, Abdul Gafoor SM. PMID: 41409372 [PubMed]
	A Case Report of a Comparative Approach in a Patient with Multiple Seborrheic Keratosis: Does It Work for SK-Like Melanoma Screening? Case Rep Dermatol Billah LM, Chiheb S, Mohamed O, Kelati A. PMID: 41409133 [PubMed]
	High BRAF variant allele frequency predicts poor outcomes in metastatic melanoma patients treated with BRAF/MEK inhibitors. J Transl Med Guida M, Apollonio B, Romano L, Spagnolo F, Quaglino P, Depenni R, Pinto R, Squicciarini T, Fucci L, Di Tullio P, Scaini MC, Maccallini MT, Indini A, Troiani T, Natalicchio I, Brugnara S, Lombardo M, Pellegrini C, Queirolo P, Perrone F, Minisini A, Tucci M, Conca R, Costabile S, Macrì M, Tanda E, Croce E, Senetta R, Fava P, Pugliese G, Pellegrini S, Melucci E, Vecchio MD, Caraglia F, Girlando S, De Summa S, Strippoli S, Italian Melanoma Intergroup (IMI). PMID: 41408295 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 44709

Page 1 of 2236



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy